Breaking News
December 15, 2018 - When should dementia patients stop driving? A new guidance for clinicians
December 15, 2018 - Researchers use INTEGRA’s VIAFLO 96/384 to streamline the experimental workflow
December 15, 2018 - Researchers discover protein involved in nematode stress response
December 15, 2018 - Cancer patients have greater risk of developing shingles, study shows
December 14, 2018 - UAlberta scientists identify biomarkers for detecting Alzheimer’s disease in saliva samples
December 14, 2018 - Study uncovers link between tube travel and spread of flu-like illnesses
December 14, 2018 - Caffeine plus another compound in coffee may fight Parkinson’s disease
December 14, 2018 - GW researchers review studies on treatments for prurigo nodularis
December 14, 2018 - Lack of peds preventive care ups unplanned hospital admissions
December 14, 2018 - Miscarriage: When Language Deepens Pain
December 14, 2018 - New method helps better understand pathological development of ALS
December 14, 2018 - Intellectually active lifestyle confers protection against neurodegeneration in Huntington’s patients
December 14, 2018 - Mammalian collagen nanofibrils become stronger and tougher with exercise
December 14, 2018 - Considerable Morbidity, Mortality Due to Animal Encounters
December 14, 2018 - Researchers find inhibiting one protein destroys toxic clumps seen in Parkinson’s disease
December 14, 2018 - How early physical therapy can lessen the long-term need for opioids
December 14, 2018 - Depression, suicide rates highest in Mountain West states
December 14, 2018 - New model could cure the potential to underestimate how quickly diseases spread
December 14, 2018 - Exercise-induced hormone activates cells critical for bone remodeling in mice
December 14, 2018 - Researchers discover new mechanism behind spread of malignant pleural mesothelioma
December 14, 2018 - Health Tip: Celebrate a Healthier Holiday
December 14, 2018 - Scalpel-free surgery enhances quality of life for Parkinson’s patients, study finds
December 14, 2018 - Early physical therapy can reduce risk, amount of long-term opioid use | News Center
December 14, 2018 - Genetic marker, predictor of early relapse in common childhood cancer discovered
December 14, 2018 - Study could lead to a potential new way of treating sepsis
December 14, 2018 - New protein complex helps embryonic stem cells to maintain their indefinite potential
December 14, 2018 - Salk professor receives $1.8 million from NOMIS Foundation for research on mechanisms to promote health
December 14, 2018 - New discovery will improve the safety and predictability of CRISPR
December 14, 2018 - Geneticists discover how sex-linked disorders arise
December 14, 2018 - New method to visualize small-molecule interactions inside cells
December 14, 2018 - Study describes mechanism that makes people more vulnerable to hunger-causing stimuli
December 14, 2018 - Chronic opioid therapy associated with increased healthcare spending and hospital stays
December 14, 2018 - Blood Types
December 14, 2018 - Obesity linked to increased risk of early-onset colorectal cancer
December 14, 2018 - Blood test helps identify distinct molecular signatures in children with cystic fibrosis
December 14, 2018 - Scientists use water to track electrical activity of nerve cells
December 14, 2018 - Recurrence of urinary tract infection may depend on bacterial strain, study shows
December 14, 2018 - GBT Announces U.S. FDA Agrees with its Proposal Relating to Accelerated Approval Pathway for Voxelotor for the Treatment of Sickle Cell Disease and GBT Plans to Submit New Drug Application (NDA)
December 14, 2018 - Partial Thromboplastin Time (PTT) Test: MedlinePlus Lab Test Information
December 14, 2018 - Common tactics for health promotion at work may be detrimental to employees with obesity
December 14, 2018 - Myths about migration and health not supported by available evidence
December 14, 2018 - Recent findings on rare genetic disorder may help develop new treatment options
December 14, 2018 - New drug shows promise in treating sarcomas
December 14, 2018 - Scientists perform lung lavage as new approach for tuberculosis diagnosis in rhinoceros
December 14, 2018 - Answering the Biggest Neurological Research Questions of Today
December 14, 2018 - Recent winners of the Nobel Medicine Prize
December 14, 2018 - KHN’s ‘What the Health?’ Insurance enrollment is lagging — and there are lots of reasons why
December 14, 2018 - Study assesses safety and efficacy of new treatment for pancreatic cancer
December 14, 2018 - Weakened metabolism of immune T cells may account for serious complications in elderly
December 14, 2018 - Study finds drug targets for Ebola, Dengue, and Zika viruses
December 14, 2018 - Face masks may offer protection against staph bacteria for hog farm workers and their household members
December 14, 2018 - Shining new light on neuron firing
December 14, 2018 - Study highlights need for personalized approach to treat ICU acquired delirium
December 14, 2018 - Soot particles from road traffic significantly contribute to air pollution
December 14, 2018 - Massage helps relieve pain, improve mobility in patients with knee osteoarthritis
December 14, 2018 - Researchers explore home healthcare nurses’ knowledge attitudes toward infection control
December 14, 2018 - Average outpatient visit in the U.S. costs nearly $500, shows new study
December 14, 2018 - Reference Infliximab, Biosimilar Equivalent for Crohn’s Disease
December 14, 2018 - New contact lens to treat eye injuries
December 14, 2018 - Acne could have a genetic basis find researchers promising new cure
December 14, 2018 - Higher physical activity associated with improved mood
December 14, 2018 - New UGA study points to optimal hypertension treatment for stroke patients
December 14, 2018 - Study highlights factors that can reduce food cravings
December 14, 2018 - Researchers discover Ebola-fighting protein in human cells
December 14, 2018 - Fentanyl surpasses heroin in cause of U.S. drug overdose deaths
December 14, 2018 - When Heart Attack Strikes, Women Often Hesitate to Call for Help
December 14, 2018 - A warning about costume contacts
December 14, 2018 - Study examines link between peripheral artery disease and heart attack
December 14, 2018 - Researchers develop biotechnological tool to produce antifungal proteins in plants
December 14, 2018 - 3D-printed adaptive aids can benefit patients with arthritis
December 14, 2018 - Chronic bullying during adolescence impacts mental health
December 14, 2018 - Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics
December 13, 2018 - Importance of cell cycle and cellular senescence in the placenta discovered
December 13, 2018 - Gold “nanoprisms” open new window into vessels and single cells
December 13, 2018 - Research findings could lead to new targets for cancer-fighting therapeutics
December 13, 2018 - Butantan Institute signs collaboration agreement with MSD to develop dengue vaccines
December 13, 2018 - Study explores how patients want to discuss symptoms with doctors
December 13, 2018 - RUDN medics first to gather scattered data on hepatitis morbidity in Somalia
December 13, 2018 - Age and gender disparities found in use of bed nets to prevent malaria in sub-Saharan Africa
December 13, 2018 - Caffeine therapy benefits developing brains of premature babies
RA Biomarker Panel IDs Patients at High Risk for Cardiovascular Events

RA Biomarker Panel IDs Patients at High Risk for Cardiovascular Events

image_pdfDownload PDFimage_print

Action Points

  • Higher rheumatoid arthritis (RA) disease activity, as measured by a multi-biomarker disease activity (MBDA) panel of biomarkers, was associated with higher rates of hospitalized infections, myocardial infarction (MI), and coronary heart disease (CHD) events.
  • The 100-point MBDA system, based on a set of 12 protein biomarkers, has been shown to correlate well with disease activity in several RA cohorts, and is commercially available from Crescendo Biosciences under the name Vectra DA.

Higher rheumatoid arthritis (RA) disease activity, as measured by a multi-biomarker disease activity (MBDA) panel, was associated with higher rates of hospitalized infections, myocardial infarction (MI), and coronary heart disease (CHD) events, analysis of Medicare data indicated.

Higher MBDA test scores were associated with increased serious infection events (HR 1.32 per 10-unit score increment, 95% CI 1.23-1.41), Jeffrey R. Curtis, MD, MPH, of the University of Alabama at Birmingham and colleagues reported.

Scores higher than 30 also were associated with increased MI (HR 1.52, 95% CI 0.92-2.49) and CHD rates (HR 1.54, 95% CI 1.01-2.34), compared with scores less than 30.

“In this large RA population predominantly consisting of older individuals, higher MBDA scores were associated with increased risk for hospitalized infection, MI and CHD events,” they wrote in Annals of the Rheumatic Diseases.

“A strong dose–response gradient existed between MBDA scores and hospitalized infections (pneumonia and sepsis). The patterns for MI and CHD events suggested more of a threshold effect, where those with the lowest level of disease activity and inflammation were at lowest risk, but gradations with higher levels of the biomarker were relatively absent,” they added.

The 100-point MBDA system is based on a set of 12 protein biomarkers, shown to correlate well with disease activity in several RA cohorts. It is commercially available from Crescendo Biosciences under the name Vectra DA. A score under 30 is considered low, 30–44 moderate, and over 44 high.

For this analysis, the researchers used national Medicare fee-for-service claims from 2010 to 2014, linking that information to patient-specific MBDA scores supplied by Crescendo.

To be included in the study, a patient needed to have at least one valid MBDA score linked to Medicare claims and at least 365 continuous days of Medicare with Part D coverage before the first valid MBDA test date.

The researchers excluded patients who had an International Classification of Diseases (ICD)-9 diagnosis code for ankylosing spondylitis, inflammatory bowel disease psoriasis, psoriatic arthritis, systemic lupus erythematosus, malignancy (except non-melanoma skin cancer), polymyalgia rheumatica, and giant cell arteritis in the 12-month baseline period. They also excluded patients who had initiated any non-tumor necrosis factor biologic or synthetic targeted disease-modifying anti-rheumatic drugs (DMARDs) in the 183 days before the index date.

Patients who had a prior MI, coronary artery bypass grafting, or percutaneous coronary intervention were not included in the MI and CHD outcome.

Because MBDA scores could be affected by an evolving outpatient infection or MI, the researchers also excluded patients from the MI and CHD analysis if they had heart attacks or coronary events in the 7 days following the MBDA test. Similarly, they excluded patients from the serious infection outcome if they had a serious infection in the 14 days after the test.

A total of 17,433 patients were eligible for the serious infection analysis and 16,796 patients for the MI and CHD outcome. Overall, the average age was 69 years; 79% were women, 81% were white, and 38% were disabled. These patients used methotrexate (54%), oral glucocorticoids (53%), non-biologic DMARDs (40%) and biologics (17%) to treat their RA.

Characteristics of patients in lower MBDA categories suggested they were younger (a 3-year difference), had a lower burden of comorbidities, and used less glucocorticoids and more biologics than patients with higher MBDA scores.

After multivariable adjustment, higher MBDA scores were associated with statistically significantly higher rates of serious infection events and higher MI and CHD rates.

Because C-reactive protein, one of the MBDA biomarkers, might influence outcomes, the researchers performed sensitivity analyses excluding it and found similar results: a 1.5-fold (CHD) and 1.7-fold (MI) elevated risk for patients in the higher disease activity category compared with the lowest.

“The current study is novel in that it leveraged a large administrative data source linked to a laboratory test provider database to address a question that neither data source by itself could address,” the authors wrote.

The results should be interpreted in light of the study design, they noted. It included predominantly older adults and findings might not apply to younger RA patients.

“However, given that the prevalence of infectious and CHD risk factors generally increases with age, we would speculate that the associations between RA disease activity and the outcomes that we studied might be even stronger in younger patients with RA,” they wrote.

This analysis was supported in part by Crescendo Bioscience, which is part of Myriad Genetics.

Curtis is a consultant for Myriad Genetics and has received research grants from them.

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-04-01T00:00:00-0400

last updated

Tagged with:

About author

Related Articles